Zenyatta Adds Quantum Dots to its Product Development Pipeline

Zenyatta Ventures Ltd. (TSXV: ZEN, “Zenyatta” or the “Company”) today announced that it has added Graphene Quantum Dots (GQDs) and Carbon Quantum Dots (CQDs) to its product development pipeline, working with its research partners Prof. Eugenia Kumacheva from the University of Toronto and Prof. Aicheng Chen from the University of Guelph. Preliminary testwork by Dr. Kumacheva, Professor of Chemistry and a Canada Research Chair in Advanced Functional Materials, along with her research team, have confirmed the relative ease with which GQDs could be produced from graphite feed from the company’s unique Albany Graphite Deposit in Northern Ontario. “Importantly, the spectroscopic properties of the GQDs we produced were consistent from experiment to experiment,” said Prof. Kumacheva. Independently, the Chen Research Group at the University of Guelph has also successfully used Albany Graphite to produce CQDs in a consistent fashion. “Employing a simple method that has the potential to be scaled to industrial sized applications allows the conversion of Albany Graphite into highly fluorescent CQDs,” Prof. Chen said. “Analysis of these CQDs confirmed not only that they are relatively easy to produce, but also that they possess high uniformity which is a highly desirable feature of any nanomaterial.” A quantum dot gets its name because it is a tiny speck of matter so small that it is effectively concentrated into a single point making it zero-dimensional like an atom. They range from between 2 to 10 nanometers in diameter, which is equivalent to 50 to 1000 atoms and it is this small size that gives quantum dots their unique properties. One interesting and very useful property is their ability to glow a particular colour after being illuminated by light (e.g. ultraviolet light). The colour light that a quantum dot emits is directly related to its size; smaller dots glow blue, larger ones glow red. Intermediate –sized dots glow green and other colours. Quantum Dots have attracted much attention recently due to their high stability, good conductivity, superior thermal, mechanical and electrical properties, environmental friendliness, low toxicity and biocompatibility. GQDs and CQDs have many next generation applications including: Bio-imaging markers, fluorescent polymers, markers for anti-counterfeiting/brand protection and many others. Zenyatta and its research partners will continue this innovative product development work to potentially create value for shareholders through Intellectual Property (“IP”) protected inventions. Zenyatta also intends to work with other leading industrial partners to co-develop IP. One of the important goals of the Company is to become an IP incubator where it can participate in IP creation across multiple industries. Mr. Peter Wood, P.Eng, P.Geo., President and COO of Zenyatta, is the “Qualified Person” for the purposes of National Instrument 43-101 and has reviewed, prepared and supervised the preparation of the technical information contained in this news release. For further information: Dr. Francis Dubé, Co-CEO & Head of Business Development and Technology Tel: +1 (289) 821-2820 Email: fdube@zenyatta.ca
  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Tyler Dunn

Director, Marketing & Communications


Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.